A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

VIRI Insider Trading (Virios Therapeutics)

Insider Ownership Percentage: 18.60%
Insider Buying (Last 12 Months): $236,881.28
Insider Selling (Last 12 Months): $0.00

Virios Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Virios Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Virios Therapeutics Share Price & Price History

Current Price: $4.23
Price Change: Price Increase of +0.05 (1.20%)
As of 06/30/2022 01:00 AM ET

This chart shows the closing price history over time for VIRI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Virios Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/23/2022Angela WalshSVPBuy2,000$4.58$9,160.003,000View SEC Filing Icon  
5/23/2022Gregory Scott DuncanCEOBuy7,500$4.52$33,900.0032,461View SEC Filing Icon  
5/17/2022William PridgenDirectorBuy13,450$4.38$58,911.0036,469View SEC Filing Icon  
3/29/2022William PridgenDirectorBuy600$4.94$2,964.00View SEC Filing Icon  
3/23/2022William PridgenDirectorBuy2,197$5.46$11,995.62View SEC Filing Icon  
1/27/2022William PridgenDirectorBuy4,180$5.98$24,996.40View SEC Filing Icon  
1/6/2022Richard James WhitleyDirectorBuy1,800$5.72$10,296.00View SEC Filing Icon  
12/23/2021Richard James WhitleyDirectorBuy200$5.72$1,144.00View SEC Filing Icon  
12/21/2021Gregory Scott DuncanCEOBuy5,000$5.52$27,600.00View SEC Filing Icon  
12/21/2021William PridgenDirectorBuy8,827$5.66$49,960.82View SEC Filing Icon  
7/7/2021William PridgenDirectorBuy942$6.32$5,953.44View SEC Filing Icon  
4/5/2021Gregory Scott DuncanCEOBuy15,675$6.17$96,714.7519,579View SEC Filing Icon  
1/29/2021William PridgenDirectorBuy3,500$7.47$26,145.00727,993View SEC Filing Icon  
1/28/2021Angela WalshVPBuy1,000$7.30$7,300.00View SEC Filing Icon  
12/17/2020William PridgenDirectorBuy1,500$11.98$17,970.00727,192View SEC Filing Icon  
See Full Table
Make Sure Your Alarm Is Set…
This early morning trade is constantly overlooked, but those who use it are retiring early!

Hi, I’m trading expert Dave Aquino and with my new guide, “How To Master The Retirement Trade”, you could be taking advantage of it as well!

The trade starts at 9:30EST…don’t be late!

Get a copy here!

>>>

SEC Filings (Institutional Ownership Changes) for Virios Therapeutics (NASDAQ:VIRI)

11.40% of Virios Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VIRI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Virios Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022UBS Group AG14,137$63K0.0%+528.3%0.170%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.241,666$1.08M0.0%+63.4%2.901%Search for SEC Filing on Google Icon
5/12/2022Cetera Advisors LLC43,944$0.20M0.0%+22.0%0.528%Search for SEC Filing on Google Icon
11/16/2021Captrust Financial Advisors40,145$0.21M0.0%N/A0.482%Search for SEC Filing on Google Icon
11/16/2021Cetera Advisors LLC48,432$0.26M0.0%+100.0%0.581%Search for SEC Filing on Google Icon
11/16/2021Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.15,856$84K0.0%+64.3%0.190%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC13,110$82K0.0%N/A0.157%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC18,499$0.12M0.0%N/A0.222%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.141,011$0.89M0.0%N/A1.693%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC22,858$0.13M0.0%+10.4%0.274%Search for SEC Filing on Google Icon
5/17/2021Masters Capital Management LLC600,000$3.44M0.1%+33.9%7.203%Search for SEC Filing on Google Icon
5/14/2021PVG Asset Management Corp55,160$0.32M1.0%N/A0.662%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.27,844$0.16M0.0%N/A0.334%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC35,219$0.26M0.0%N/A0.450%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC95,230$0.72M0.0%N/A1.216%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Virios Therapeutics logo
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Read More on Virios Therapeutics

Today's Range

Now: $4.23
Low: $3.89
High: $4.25

50 Day Range

MA: $4.11
Low: $3.31
High: $4.89

52 Week Range

Now: $4.23
Low: $3.30
High: $7.21

Volume

2,391 shs

Average Volume

19,578 shs

Market Capitalization

$35.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Virios Therapeutics?

Virios Therapeutics' top insider investors include:
  1. William Pridgen (Director)
  2. Gregory Scott Duncan (CEO)
  3. Angela Walsh (SVP)
  4. Angela Walsh (VP)
  5. Richard James Whitley (Director)
Learn More about top insider investors at Virios Therapeutics.
The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>